L. Benazzato

Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?

R. D’Incà, E. Dal Pont, Vincenza Di Leo et al. · The American Journal of Gastroenterology · 2008 · 209 citations

Oxidative DNA Damage in the Mucosa of Ulcerative Colitis Increases With Disease Duration and Dysplasia

R. D’Incà, R. Cardin, L. Benazzato et al. · Inflammatory Bowel Diseases · 2003 · 112 citations · Full text

Infliximab in the treatment of Crohn's disease: Predictors of response in an Italian multicentric open study

Ambrogio Orlando, Elisabetta Colombo, Anna Kohn et al. · Digestive and Liver Disease · 2005 · 77 citations

Inflammation, Anti-inflammatory, Gastroenterology +4

Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment

L. Benazzato, R. D’Incà, Francesco Grigoletto et al. · Digestive and Liver Disease · 2004 · 70 citations

Inflammation, Intensive Medical Treatment, Acute Care +4

Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients

Antonio Di Sabatino, Rachele Ciccocioppo, L. Benazzato et al. · Alimentary Pharmacology & Therapeutics · 2004 · 69 citations · Full text